Transporter-Mediated Hepatic Uptake Plays an Important Role in the Pharmacokinetics and Drug-Drug Interactions of Montelukast-Reference-Cited by-同舟云学术

Transporter-Mediated Hepatic Uptake Plays an Important Role in the Pharmacokinetics and Drug-Drug Interactions of Montelukast

Published:2016-11-18 Issue:3 Volume:101 Page:406-415
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Varma MV¹,Kimoto E¹,Scialis R¹,Bi Y¹,Lin J¹,Eng H¹,Kalgutkar AS²,El-Kattan AF²,Rodrigues AD¹,Tremaine LM¹

Affiliation:

1. Pharmacokinetics, Dynamics and Metabolism; Pfizer Inc; Groton Connecticut USA

2. Pharmacokinetics, Dynamics and Metabolism; Pfizer Inc; Cambridge Massachusetts USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference50 articles.

1. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group;Reiss;Arch. Intern. Med.,1998

2. A review of montelukast in the treatment of asthma and allergic rhinitis;Nayak;Expert Opin. Pharmacother.,2004

3. Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile;Balani;Drug Metab. Dispos.,1997

4. Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females;Cheng;Pharm. Res.,1996

5. Hepatic microsomal metabolism of montelukast, a potent leukotriene D4 receptor antagonist, in humans;Chiba;Drug Metab. Dispos.,1997

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic Determinants of Daprodustat Drug–Drug Interactions and Pharmacokinetics in Hepatic Dysfunction and Chronic Kidney Disease: Significance of OATP1B‐CYP2C8 Interplay;Clinical Pharmacology & Therapeutics;2024-02-26

2. Open‐label, drug–drug interaction study between the HIV‐1 maturation inhibitor GSK3640254 and a metabolic probe cocktail in healthy participants;British Journal of Clinical Pharmacology;2023-03-13

3. Comparative analysis of CYP2C8-medidated drug-drug interactions produced by CYP2C8 inhibitors, gemfibrozil versus clopidogrel, focusing on the inhibition of drug distribution in UDP-glucuronosyltransferase prior to oxidation;2023-01-09

4. Plasma Protein Binding Refinement of the Extended Clearance Classification System: Subclasses for Predicting Hepatic Uptake or Renal Clearance for Classes 1B and 3B;European Journal of Drug Metabolism and Pharmacokinetics;2022-11-28

5. Inhibition of CYP2C8 by Acyl Glucuronides of Gemfibrozil and Clopidogrel: Pharmacological Significance, Progress and Challenges;Biomolecules;2022-09-01